Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma

This study has been completed.
Sponsor:
Collaborators:
Research Foundation Flanders
Agentschap voor Innovatie door Wetenschap en Technologie
Information provided by:
Katholieke Universiteit Leuven
ClinicalTrials.gov Identifier:
NCT00495924
First received: July 2, 2007
Last updated: July 7, 2009
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):